home / stock / lrmr / lrmr news


LRMR News and Press, Larimar Therapeutics Inc. From 03/14/24

Stock Information

Company Name: Larimar Therapeutics Inc.
Stock Symbol: LRMR
Market: NASDAQ
Website: larimartx.com

Menu

LRMR LRMR Quote LRMR Short LRMR News LRMR Articles LRMR Message Board
Get LRMR Alerts

News, Short Squeeze, Breakout and More Instantly...

LRMR - Larimar Therapeutics GAAP EPS of -$0.30 misses by $0.06

2024-03-14 17:09:11 ET More on Larimar Therapeutics Larimar Therapeutics rises after pricing $150M stock offering Larimar Therapeutics announces proposed underwritten public offering Read the full article on Seeking Alpha For further details see: Larimar ...

LRMR - Larimar Therapeutics Reports Fourth Quarter and Full Year 2023 Operating and Financial Results and Provides Update on Nomlabofusp Development

Positive top-line data from Phase 2 dose exploration study of nomlabofusp, which was generally well-tolerated, with dose-dependent increases in tissue frataxin levels observed Initiated discussions with the Food and Drug Administration (FDA) on the potential use of tissue frataxin levels ...

LRMR - Expected US Company Earnings on Tuesday, March 12th, 2024

Koninklijke KPN NV (KKPNF) is expected to report for Q4 2023 ECA Marcellus Trust I Unit (ECTM) is expected to report for Q4 2023 San Juan Basin Royalty Trust (SJT) is expected to report for Q4 2023 Avenir Wellness Solutions Inc (AVRW) is expected to report for Q4 2023 Carmell Corp...

LRMR - Larimar Therapeutics Announces the Dosing of the First Patient in Long-term Open Label Extension Study for Nomlabofusp in Patients with Friedreich's Ataxia

Study will inform on long-term safety profile and tissue frataxin levels OLE initiated with 25 mg daily subcutaneous injections of nomlabofusp Frataxin data and safety data from the OLE study are intended to help support a potential Biologics License Application (“BLAȁ...

LRMR - Larimar Therapeutics to Present at the Leerink Partners Global Biopharma Conference

BALA CYNWYD, Pa., March 06, 2024 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that members of the company’s management te...

LRMR - Top 10 best performing biotech stocks of 2024 so far

2024-03-06 11:25:10 ET Over the past 3 months the biotech space is +30.4% and has only been outperformed by semiconductors, computer processing hardware and the computer peripherals industries. Additionally, the biotech sector is +13.6% in 2024, outdoing all of the major market aver...

LRMR - Larimar Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Shares

BALA CYNWYD, Pa., Feb. 16, 2024 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced the closing of its previously announced underwritten public o...

LRMR - (LRMR) Investment Report

2024-02-16 10:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

LRMR - COIN, LRMR, SHLS, GLBE, TRV showing five-day upward surge

2024-02-15 09:45:10 ET Coinbase Global Inc (COIN) COIN is trading UP for the last 5 days, and it at trading at $168.00 with volume of 8,158,758 and a one day change of $7.62 (4.75%). Coinbase Global Inc has a 52-week low of 32.58 and a 52-week high of $121.46. The business's 50-day ...

LRMR - DTSS, TNON and BREA among mid-day movers

2024-02-14 13:54:31 ET More on Mid-day movers & stocks. Financial information for Brera Holdings PLC Financial information for Datasea Seeking Alpha’s Quant Rating on Tenon Medical Historical earnings data for Tenon Medical Financial inform...

Previous 10 Next 10